Venker Eric
Roivant Sciences Ltd. · President & Immunovant CEO
Venker Eric is listed in filings as President & Immunovant CEO at Roivant Sciences Ltd.. This profile follows SEC Form 4 activity through May 22, 2026, including sale activity. Recent filings connect the profile to Roivant Sciences Ltd. (ROIV) and Immunovant, Inc. (IMVT). The current snapshot covers public activity from Nov 24, 2025 to May 22, 2026. Reported amounts are shown as $142.9K to $770.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $4M200k shares | SellDec 9, 2025 | $20.85 | $34.96 | |
| $4M200k shares | SellDec 23, 2025 | $22.45 | $34.96 | |
| $2M75k shares | SellDec 24, 2025 | $22.53 | $34.96 | |
| $4M200k shares | SellJan 12, 2026 | $21.92 | $34.96 | |
| $6M200k shares | SellMar 17, 2026 | $28.24 | $34.96 | |
| $6M200k shares | SellApr 20, 2026 | $29.59 | $34.96 | |
| $5M200k shares | SellFeb 13, 2026 | $26.49 | $34.96 |